GC32904
Enasidenib Mesylate
Also listed as Enasidenib mesylate (AG-221 mesylate)
Enasidenib mesylate (AG-221 mesylate) is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes
ChemicalCAS1650550-25-6MW569.48FormulaC20H21F6N7O4S
- CAS number
- 1650550-25-6
- Molecular weight
- 569.48
- Formula
- C20H21F6N7O4S
- Solubility
- DMSO ： ≥ 100 mg/mL (175·60 mM)
- InChIKey
- ORZHZQZYWXEDDL-UHFFFAOYSA-N
- Catalogue number
- GC32904
- Brand
- GLPBIO
Computed properties PubChem CID 90480031 · TPSA 171 Ų · H-bond donors 4 · H-bond acceptors 17
- TPSA
- 171 Ų
- H-bond donors
- 4
- H-bond acceptors
- 17
- Rotatable bonds
- 6
- Heavy atoms
- 38
SMILES CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O.CS(=O)(=O)O
Computed descriptors from PubChem (CID 90480031), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il